Nov 5 (Reuters) – Laboratorios Farmaceuticos Rovi, S.A. : * 9-MONTH NET PROFIT €162.8 MILLION * 9-MONTH OPERATING REVENUE €610.2 MILLION * UPGRADES ITS 2026 OPERATING REVENUE GUIDANCE * NOW EXPECTS
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
SINGAPORE, Nov 5 (Reuters) - Oil, chip stocks and the dollar were under pressure in…
By Anton Bridge Nov 5 (Reuters) - China's state planner has told Japanese investor SoftBank…
Nov 5 (Reuters) - Capgemini SE: * CAPGEMINI SELECTED BY THE EUROPEAN COMMISSION TO LEAD…
New Delhi [India], October 31: A place in search results can open the door to…
By Daniel Leussink TOKYO, Nov 5 (Reuters) - Toyota on Thursday booked its first profit…
SEOUL, Nov 5 (Reuters) - South Korea plans to introduce taxes on digital assets in…